Filtered By:
Nutrition: Sodium
Countries: Georgia Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2 results found since Jan 2013.

Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ASH 2021
RARITAN, N.J., November 4, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 45 company-sponsored abstracts, including 11 oral presentations, plus more than 35 investigator-initiated studies will be featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is taking place at the Georgia World Congress Center in Atlanta and virtually from December 11-14, 2021.“We are committed to advancing the science and treatment of hematologic malignancies and look forward to presenting the latest research from our robust portfolio and pipeline during ASH...
Source: Johnson and Johnson - November 5, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Cardiac output changes after osmotic therapy in neurosurgical and neurocritical care patients: A systematic review of the clinical literature
ConclusionsMannitol or HTS administration seems to induce an enhancement of cardiac performance; being more prominent after HTS infusion. This effect combined with mannitol‐induced enhancement of diuresis and HTS‐promoted increase of plasma sodium concentration could partially explain the effects of osmotherapy on cerebral hemodynamics.
Source: British Journal of Clinical Pharmacology - December 1, 2017 Category: Drugs & Pharmacology Authors: Georgia Tsaousi, Elisabetta Stazi, Marco Cinicola, Federico Bilotta Tags: SYSTEMATIC REVIEW AND META ‐ANALYSIS Source Type: research